Results 61 to 70 of about 1,182,694 (285)

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

open access: yesMolecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian   +10 more
wiley   +1 more source

Excursions of diffusion processes and continued fractions [PDF]

open access: yes, 2010
It is well-known that the excursions of a one-dimensional diffusion process can be studied by considering a certain Riccati equation associated with the process.
Comtet, Alain, Tourigny, Yves
core   +5 more sources

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

open access: yesMolecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert   +13 more
wiley   +1 more source

Size-biased diffusion limits and the inclusion process [PDF]

open access: green, 2023
Paul Chleboun   +2 more
openalex   +1 more source

Relativistic diffusion processes and random walk models [PDF]

open access: yes, 2007
The nonrelativistic standard model for a continuous, one-parameter diffusion process in position space is the Wiener process. As well-known, the Gaussian transition probability density function (PDF) of this process is in conflict with special relativity,
C. W. Gardiner   +17 more
core   +2 more sources

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

open access: yesMolecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser   +14 more
wiley   +1 more source

Computer-Aided Design in Electromagnetics - the Case for Surface Impedance Boundary Conditions

open access: yesAdvances in Electrical and Computer Engineering, 2012
Surface impedance boundary conditions (SIBCs) have been successfully used for over 70 years in both analytical and numerical computation. With the need to model increasingly complex geometries and smaller artifacts, its importance in computer-aided ...
IDA, N., Di RIENZO, L., YUFEREV, S.
doaj   +1 more source

Two Stochastic Differential Equations for Modeling Oscillabolastic-Type Behavior

open access: yesMathematics, 2020
Stochastic models based on deterministic ones play an important role in the description of growth phenomena. In particular, models showing oscillatory behavior are suitable for modeling phenomena in several application areas, among which the field of ...
Antonio Barrera   +2 more
doaj   +1 more source

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

open access: yesMolecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy